SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-027163
Filing Date
2022-07-28
Accepted
2022-07-27 17:36:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20004337x2_defa14a.htm DEFA14A 7960
2 ny20004337x2_img01.jpg GRAPHIC 810854
3 ny20004337x2_img02.jpg GRAPHIC 750292
  Complete submission text file 0001140361-22-027163.txt   2159568
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37929 | Film No.: 221112010
SIC: 2834 Pharmaceutical Preparations